Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1923]
News [3530]
Articles [90]
Editorials [5]
Conferences [156]
elearning [19]
Elucidation and pharmacological targeting of tumour checkpoint dependencies
Dr Andrea Califano - Colombia University Medical Centre, New York, USA
Elucidation and pharmacological targeting of tumour checkpoint dependencies ( Dr Andrea Califano - Colombia University Medical Centre, New York, USA )
28 Apr 2016
Metastasis intiation mediated by thrombospondin 2
Dr Ilaria Malanchi - Crick Institute, London, UK
Metastasis intiation mediated by thrombospondin 2 ( Dr Ilaria Malanchi - Crick Institute, London, UK )
27 Apr 2016
New technology can potentially overcome CAR T-cell limitations
Dr Philip Low - Purdue University, West Lafayette, USA
New technology can potentially overcome CAR T-cell limitations ( Dr Philip Low - Purdue University, West Lafayette, USA )
27 Apr 2016
AML17 Trial results: maximum dosage of daunorubicin in AML
Dr Mike Dennis - Christie Hospital NHS Foundation Trust, Manchester, UK
AML17 Trial results: maximum dosage of daunorubicin in AML ( Dr Mike Dennis - Christie Hospital NHS Foundation Trust, Manchester, UK )
27 Apr 2016
BSH 2016: Expert discussion on idelalisib
Dr George Follows and Dr Andrew Zelenetz
BSH 2016: Expert discussion on idelalisib ( Dr George Follows and Dr Andrew Zelenetz )
27 Apr 2016
BSH 2016: Expert discussion on front line care in CLL
Dr George Follows and Dr Andrew Zelenetz
BSH 2016: Expert discussion on front line care in CLL ( Dr George Follows and Dr Andrew Zelenetz )
27 Apr 2016
Comparison of three different PD-L1 diagnostic tests shows a high degree of...
Dr Marianne Ratcliffe - AstraZeneca, UK
Comparison of three different PD-L1 diagnostic tests shows a high degree of concordance ( Dr Marianne Ratcliffe - AstraZeneca, UK )
26 Apr 2016
Next-generation sequencing in the lymphoid malignancies
Dr Aaron Logan - UCSF, San Fransisco, USA
Next-generation sequencing in the lymphoid malignancies ( Dr Aaron Logan - UCSF, San Fransisco, USA )
26 Apr 2016
Mutational clonality and intratumour heterogeneity as biomarkers for cancer...
Dr Nicholas McGranahan - Crick Institute, London, UK
Mutational clonality and intratumour heterogeneity as biomarkers for cancer immunotherapy ( Dr Nicholas McGranahan - Crick Institute, London, UK )
26 Apr 2016
Retroviral replicating vectors for cancer-targeted gene therapy and...
Dr Noriyuki Kasahara - Miami University School of Medicine, Miami, USA
Retroviral replicating vectors for cancer-targeted gene therapy and immunotherapy ( Dr Noriyuki Kasahara - Miami University School of Medicine, Miami, USA )
26 Apr 2016
NY-ESO-1 immunotherapy for ovarian cancer
Dr Kunle Odunsi - Roswell Park Cancer Institute, Buffalo, USA
NY-ESO-1 immunotherapy for ovarian cancer ( Dr Kunle Odunsi - Roswell Park Cancer Institute, Buffalo, USA )
26 Apr 2016
Normal and neoplastic stem cells
Prof Irving L Weissman - Stanford University School of Medicine, Stanford, USA
Normal and neoplastic stem cells ( Prof Irving L Weissman - Stanford University School of Medicine, Stanford, USA )
26 Apr 2016

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation